Trials and PIs

View all posts »

ALPHA OMEGA with Dr Daan Kromhout

Aug 29, 2010 10:58 EDT


Dr Daan Kromhout (Wageningen University, the Netherlands) discusses ALPHA OMEGA: the effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients.

Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.

See:
Alpha Omega Trial: n-3 fatty acids fail to reduce cardiovascular events in post-MI patients






Your comments
ALPHA OMEGA with Dr Daan Kromhout
# 1 of 2
September 2, 2010 04:04 (EDT)
William Feeman, Jr
Over the last 25 years I have used a combination of fish oil (EPA and DHA totaling about 1 gm daily) in combination with 81 mg Aspirin in a primary prevention scenario with patients with dyslipidemia. My treated patients, so far this century, have sustained only two fatal acute myocardial infarctions, on in a cigarette smoker with very high blood pressure (well controlled by medication) and wonderful lipids, and the other in an insulin-dependent diabetic (x 40 years), whose lipids and blood pressure were controlled very well, whereas he controlled his blood sugar by self-regulating his insulin therapy, with relatively poor glucose control. Still, this latter patient lived to age 72 years. (Control of lipids and blood pressure are as defined in the 1 August 2008 issue of the American Journal of Cardiology, under the title of "Treating Lipids in the General Population." A follow-up letter describing the graph and diabetes will be published in the next issue of the American Journal of Cardiology.)
# 2 of 2
November 17, 2010 01:49 (EST)
channesh chinnapla
the topic is confusing

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!